Table 3.
Compd. | CRTH2 Binding (IC50 a) | Log D7.4 | Rat Hep Clint b | Hum Mic Clint c | Agonism EOS Shape Change d | CRTH2 Ca2+ (IC50e) |
---|---|---|---|---|---|---|
57 | 18 nM | 0.4 | <4 | 6 | IA | 517 nM |
58 | 316 nM | <3 | 5 | |||
59 | 10 nM | 1.0 | <3 | 11 | IA | |
60 | 1.0 nM | <3 | <3 | IA | 9 nM | |
61 | 0.3 nM | 0.8 | <3 | <3 | yes |
a Radiometric binding assay, n > 2 measurements. b Rat hepatocyte intrinsic clearance (µL/min/1 × 106 cells). c Human liver microsomes intrinsic clearance (µL/min/mg). d Agonism in eosinophil shape change, IA refers to <10% response of DK-PGD2. e Antagonism of PGD2-mediated Ca2+ flux in human CHO cells, n > 2 measurements.